Abstract: A compressible photonic crystal comprising a polymer with an ordered array of voids, the photonic crystal having a reflectance in a first wavelength range for light incident to its incident surface and its opposing incident surface; wherein compression against at least a portion of at least one of the surfaces shifts the reflectance to a second wavelength range in at least that portion of that surface. The crystal may be used in authentication devices of various types.

Abstract: There is provided a novel process for preparing polyamides (in particular cyclic and hairpin polyamides) comprising the step of coupling an amine with a Boc-protected amino acid monomer in the presence of diphosgene and/or triphosgene. Such a process may be performed on a solid or solution phase.

Abstract: Iodylbenzene derivatives substituted with electron donating as well as electron withdrawing groups on the aromatic ring are used as precursors in aromatic nucleophilic substitution reactions. The iodyl group (IO2) is regiospecifically substituted by nucleophilic fluoride to provide the corresponding fluoroaryl derivatives. No-carrier-added [F-18]fluoride ion derived from anhydrous [F-18](F/Kryptofix, [F-18]CsF or a quaternary ammonium fluoride (e.g., Me4NF, Et4NF, n-Bu4NF, (PhCH2)4NF) exclusively substitutes the iodyl moiety in these derivatives and provides high specific activity F-18 labeled fluoroaryl analogs. Iodyl derivatives of a benzothiazole analog and 6-iodyl-L-dopa derivatives have been synthesized as precursors and have been used in the preparation of no-carrier-added [F-18]fluorobenzothiazole as well as 6-[F-18]fluoro-L-dopa.

Abstract: The invention relates to N-hydroxylsulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxylsulfonamide derivatives release NHO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxylsulfonamide derivatives.

Abstract: A non-aqueous electrolyte secondary battery including a unit cell including a positive electrode, a negative electrode, a separator disposed between the positive electrode and the negative electrode, and a non-aqueous electrolyte, the positive electrode capacity being greater than the negative electrode capacity, and at least a portion of the non-aqueous electrolyte is gasified during charging.

Abstract: Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of diseases and disorders, such as learning, cognitive activities, and analgesia, particularly in alleviating and/or reducing neuropathic pain. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.

Abstract: A method for treating or preventing a T-cell-mediated autoimmune disease is provided herein, the method including administering to a mammal in need thereof a therapeutically effective amount of soluble CD137 or CD137pos regulatory T cells. Also provided are pharmaceutical compositions for treating or preventing T-cell-mediated autoimmune diseases, the pharmaceutical compositions including a therapeutically effective amount of soluble CD137 or CD137pos regulatory T cells and a pharmaceutically-acceptable carrier.

Abstract: A mesoporous, nanocrystalline, metal oxide construct particularly suited for capacitive energy storage that has an architecture with short diffusion path lengths and large surface areas and a method for production are provided. Energy density is substantially increased without compromising the capacitive charge storage kinetics and electrode demonstrates long term cycling stability. Charge storage devices with electrodes using the construct can use three different charge storage mechanisms immersed in an electrolyte: (1) cations can be stored in a thin double layer at the electrode/electrolyte interface (non-faradaic mechanism); (2) cations can interact with the bulk of an electroactive material which then undergoes a redox reaction or phase change, as in conventional batteries (faradaic mechanism); or (3) cations can electrochemically adsorb onto the surface of a material through charge transfer processes (faradaic mechanism).

Abstract: An automatic brightness adjusting method and apparatus for image signal processor (ISP) is provided. The image processing apparatus may include a histogram generating unit, a cumulative distribution function calculator, and a histogram equalization (HE) unit. The histogram generating unit may generate a histogram of brightness values of pixels in an input image. The cumulative distribution function calculator may generate a cumulative distribution function and an inverse cumulative distribution function, based on the generated histogram. The HE unit may generate a conversion function based on the cumulative distribution function and the inverse cumulative distribution function, and may apply HE to the input image based on the conversion function so as to generate an output image.

Abstract: Differential phase shift (DPS) quantum key distribution (QKD) is provided, where the average number of photons per transmitted pulse is predetermined such that the secure key generation rate is maximal or nearly maximal, given other system parameters. These parameters include detector quantum efficiency, channel transmittance and pulse spacing (or clock rate). Additional system parameters that can optionally be included in the optimization include baseline error rate, sifted key error rate, detector dead time, detector dark count rate, and error correction algorithm performance factor. The security analysis leading to these results is based on consideration of a hybrid beam splitter and intercept-resend attack.

Abstract: In an embodiment, a method of conducting a high temperature chemical reaction that produces hydrogen or synthesis gas is described. The high temperature chemical reaction is conducted in a reactor having at least two reactor shells, including an inner shell and an outer shell. Heat absorbing particles are included in a gas stream flowing in the inner shell. The reactor is heated at least in part by a source of concentrated sunlight. The inner shell is heated by the concentrated sunlight. The inner shell re-radiates from the inner wall and heats the heat absorbing particles in the gas stream flowing through the inner shell, and heat transfers from the heat absorbing particles to the first gas stream, thereby heating the reactants in the gas stream to a sufficiently high temperature so that the first gas stream undergoes the desired reaction(s), thereby producing hydrogen or synthesis gas in the gas stream.

Abstract: This invention relates to the novel identification of arginase as an enzymatic activity which can reverse inhibition of neuronal regeneration in the central and peripheral nervous system. Assays to monitor the effects of various agents on arginase expression and thus on neuronal regeneration and repair and to identify agents which will block or promote the inhibitory effects on neuronal outgrowth are provided. This invention also relates to compositions and methods using agents that can reverse the inhibitory effects of myelin on neural regeneration by affecting arginase activity or putrescine and derivative polyamine levels in a neuron.

Abstract: The subject invention concerns compounds having activity as inhibitors of proteasomes and methods of using the subject compounds. In one embodiment, a compound of the invention has the chemical structure shown in formula I: or a pharmaceutically acceptable salt or hydrate thereof. In another embodiment, a compound of the invention has the chemical structure shown in formula II: or a pharmaceutically acceptable salt or hydrate thereof.

Abstract: A method of creating a noninvasive predictor of both physiologic and imposed patient effort of breathing from airway pressure and flow sensors attached to the patient using an adaptive mathematical model. The patient effort is commonly measured via work of breathing, power of breathing, or pressure-time product of esophageal pressure and is important for properly adjusting ventilatory support for spontaneously breathing patients. The method of calculating this noninvasive predictor is based on linear or non-linear calculations using multiple parameters derived from the above-mentioned sensors.

Abstract: A power converter has a controller that uses as input a voltage output of the converter and provides a signal for controlling the duty cycle without the need for current sensing. In one embodiment, the output characteristic of the converter is similar to the output characteristic provided by conventional adaptive voltage positioning (AVP) controllers, but by eliminating the need to sense current, the converter's cost, complexity, and power consumption can be reduced.

Abstract: Functionalized chondroitin sulfate, cross-linked polymer matrices comprising functionalized chondroitin sulfate, and methods of making and using the same are provided. Such polymer matrices may be used for tissue engineering, reconstructing cartilage, and the like. Kits are also provided for detection of cartilage degrading enzymes.

Abstract: It has been discovered that granulocyte macrophage colony stimulating factor (“GM-CSF”) promotes migration of activated (but not differentiating) keratinocytes to wound sites. It was also discovered that GM-CSF increases the quantity and improves the quality of collagen. This growth factor specifically increases migration of keratinocytes of the “wound” phenotype but does not have significant effects upon differentiated keratinocytes. Examples demonstrate reversal of skin impairment in multiple animal models of diabetic skin imparment when provided in an effective amount over an effective time period. The examples also demonstrate the efficacy of the formulations in cosmetic applications.

Abstract: The present invention provides an enzymatic and a chemical synthesis of melanins and novel melanins.

Abstract: An electromagnetically induced transparent (EIT)-based photonic logic gate. The electromagnetically induced transparent (EIT)-based photonic logic gate is a photonic crystal (PC) and electromagnetically induced transparent (EIT)-based stacked layer which is constituted by a photonic crystal (PCs) layers and an electromagnetically induced transparent material layers. For the photonic crystal (PCs) and electromagnetically induced transparent (EIT)-based stacked layer, a probe field is an input signal which is emitted from the photonic crystal layer and a control field is a control signal which is emitted from the electromagnetically induced transparent material layers. The probe field is an input signal which is emitted from the electromagnetically induced transparent material layers. By varying the detune frequency of probe field and Rabi frequency of control field, the band gap structure can be adjusted.

Abstract: Provided are novel biocompatible copolymers and compositions comprising the copolymers. The copolymers are non-toxic and typically have an LCST below 37° C. Compositions comprising the copolymers can be used for wound treatment, as a cellular growth matrix or niche and for injection into cardiac tissue to repair and mechanically support damaged tissue. The copolymers comprise numerous ester linkages so that the copolymers are erodeable in situ. Degradation products of the copolymers are soluble and non-toxic. The copolymers can be amine-reactive so that they can conjugate with proteins, such as collagen. Active ingredients, such as drugs, can be incorporated into compositions comprising the copolymers.